tiprankstipranks
Trending News
More News >
Biocept (BIOCQ)
OTHER OTC:BIOCQ
US Market

Biocept (BIOCQ) Income Statement

Compare
1,245 Followers

Biocept Income Statement

Last quarter (Q2 2023), Biocept's total revenue was $589.00K, a decrease of -12.48% from previous quarter. In Q2, Biocept's net income was $-3.63M. See Biocept’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.86M$ 61.25M$ 27.46M$ 5.53M
Gross Profit
$ -2.58M$ 23.48M$ 6.12M$ -5.45M
Operating Expenses
$ 29.40M$ 25.89M$ 21.59M$ 17.61M
Depreciation and Amortization
$ 1.66M$ 1.53M$ 1.00M$ 773.31K
EBITDA
$ -30.24M$ -879.00K$ -16.57M$ -24.11M
Operating Income
$ -31.98M$ -2.41M$ -15.47M$ -23.06M
Other Income/Expenses
$ -229.00K$ -290.00K$ -2.34M$ -2.08M
Pretax Income
$ -32.21M$ -2.70M$ -17.81M$ -25.14M
Net Income
$ -32.09M$ -2.82M$ -17.81M$ -25.14M
Per Share Metrics
Basic EPS
$ -56.78$ -5.73$ -45.10$ -365.01
Diluted EPS
$ -56.78$ -5.73$ -45.10$ -365.01
Weighted Average Shares Outstanding
565.13K 492.53K 394.84K 68.87K
Weighted Average Shares Outstanding (Diluted)
565.13K 492.53K 394.84K 68.87K
Currency in USD

Biocept Earnings and Revenue History